1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Vaccination against hepatitis B virus among people who inject drugs – A 20 year experience from a Swedish needle exchange program
(
- Contribution to journal › Article
- 2015
-
Mark
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.
(
- Contribution to journal › Article
- 2014
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013
(
- Contribution to journal › Scientific review
-
Mark
Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naive HIV-1-infected individuals over 144 weeks: An open-label randomized controlled trial
(
- Contribution to journal › Article
- 2012
-
Mark
Prevalence of sexually transmitted infections among women attending antenatal clinics in Tanga, north eastern Tanzania
(
- Contribution to journal › Article
- 2011
-
Mark
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010
(
- Contribution to journal › Scientific review
-
Mark
Bilirubin-A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy
(
- Contribution to journal › Article
-
Mark
Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naive HIV-1 infected patients
(
- Contribution to journal › Article
-
Mark
Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program.
(
- Contribution to journal › Article